Lannett obtained approval from the FDA to market a copy of Sandoz's phentermine hydrochloride, which is used as a short-term treatment for obesity along with exercise and diet. The company plans to launch the generic this quarter, CEO and President Arthur Bedrosian said.
The recess appointment of Dr. Donald Berwick as CMS chief is welcomed by a number of health IT leaders. Dr. John Halamka, CIO of Boston-based Beth Israel Deaconess Medical Center, said Berwick is the best choice "to implement the mandates of health reform and improve the quality, safety and efficiency of health care in the U.S."
President Barack Obama has nominated Dr. Donald Berwick, a pediatrician and professor at Harvard Medical School and Harvard School of Public Health, to lead the CMS. As administrator, Berwick will be responsible for carrying out the major provisions of the health reform law that involve Medicare and Medicaid.